Two decades after leaving India, Anil Koul has returned to helm its Institute of Microbial Technology. For Dengue Awareness Month, we caught up with him to learn how he's hoping to combat this tropical scourge and another disease that kills over a million worldwide.
For the fifth anniversary of the London Declaration, we're sharing the steps the company has taken to fulfill its promise to fight neglected tropical diseases—including the development of a chewable form of mebendazole.
Healthcare providers who contracted TB on the job. A microbiologist researching new treatments. An activist ensuring attention is paid to one of the world’s greatest health threats. These young leaders share one goal: to help end TB.
Johnson & Johnson is launching a new collaboration toadvance health equity by building climate resilience in U.S.medical clinics that face floods, fires, heat waves and more. This initiative is just one of the ways the company is working to bolster healthcare in communities that are disproportionately impacted byclimate change. Learn more from the company’s Chief Sustainability Officer.
As he assumes his role as the company’s Chief Executive Officer, we’re sharing some facts about the respected business leader, who has deep roots at the company—and a commitment to helping improve health for people around the world.